Merck (MRK) Net Income towards Common Stockholders (2009 - 2026)

Merck (MRK) has reported Net Income towards Common Stockholders for 18 consecutive years, with -$1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 130.19% year-over-year to -$1.3 billion in Q2 2026; TTM through Jun 2026 was $3.2 billion, a 80.7% decrease from a year earlier, with the FY2025 full-year figure at $18.3 billion, up 6.6% from the prior year.
• Net Income towards Common Stockholders was -$1.3 billion for Q2 2026 at Merck, up from -$4.2 billion in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $5.8 billion in Q3 2025 and troughed at -$6.0 billion in Q2 2023.
• A 5-year average of $2.5 billion and a median of $3.5 billion in 2022 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders sank 251.23% in 2023 and surged 405.38% in 2024, its largest moves.
• Over 5 years, Net Income towards Common Stockholders stood at $3.0 billion in 2022, then tumbled by 140.62% to -$1.2 billion in 2023, then surged by 405.38% to $3.7 billion in 2024, then retreated by 20.89% to $3.0 billion in 2025, then sank by 145.14% to -$1.3 billion in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$1.3 billion (Q2 2026), -$4.2 billion (Q1 2026), and $3.0 billion (Q4 2025), per Business Quant data.